Published in J Infect Dis on August 01, 2011
Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol (2013) 3.00
Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis (2015) 2.48
Reducing HPV-associated cancer globally. Cancer Prev Res (Phila) (2012) 1.46
Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis. BMJ (2015) 1.43
Completion of the human papillomavirus vaccine series among insured females between 2006 and 2009. Cancer (2012) 1.35
Sex-specific immunization for sexually transmitted infections such as human papillomavirus: insights from mathematical models. PLoS Med (2011) 1.10
Modeling preventative strategies against human papillomavirus-related disease in developed countries. Vaccine (2012) 1.08
Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe. BMC Cancer (2013) 1.08
Prevention of HPV-related cancers in Norway: cost-effectiveness of expanding the HPV vaccination program to include pre-adolescent boys. PLoS One (2014) 1.06
Towards the eradication of HPV infection through universal specific vaccination. BMC Public Health (2013) 1.01
HPV vaccine acceptability among men: a systematic review and meta-analysis. Sex Transm Infect (2013) 0.97
The road ahead for cervical cancer prevention and control. Curr Oncol (2014) 0.94
Genital Chlamydia trachomatis: understanding the roles of innate and adaptive immunity in vaccine research. Clin Microbiol Rev (2014) 0.92
Human papilloma virus vaccination: impact and recommendations across the world. Ther Adv Vaccines (2015) 0.89
Population effectiveness, not efficacy, should decide who gets vaccinated against human papillomavirus via publicly funded programs. J Infect Dis (2011) 0.88
Incremental benefits of male HPV vaccination: accounting for inequality in population uptake. PLoS One (2014) 0.86
Vaccination against human papilloma virus infection in male adolescents: knowledge, attitudes, and acceptability among parents in Italy. Hum Vaccin Immunother (2014) 0.82
Estimating the cost-effectiveness profile of a universal vaccination programme with a nine-valent HPV vaccine in Austria. BMC Infect Dis (2016) 0.81
Is expanding HPV vaccination programs to include school-aged boys likely to be value-for-money: a cost-utility analysis in a country with an existing school-girl program. BMC Infect Dis (2014) 0.81
HPV Vaccine utilization, Alberta 2008/09 - 2013/14 School year. BMC Infect Dis (2016) 0.80
Impact of coverage-dependent marginal costs on optimal HPV vaccination strategies. Epidemics (2015) 0.79
Vaccinating Girls and Boys with Different Human Papillomavirus Vaccines: Can It Optimise Population-Level Effectiveness? PLoS One (2013) 0.79
Efficacy of vaccination against HPV infections to prevent cervical cancer in France: present assessment and pathways to improve vaccination policies. PLoS One (2012) 0.78
Monitoring for Human Papillomavirus Vaccine Impact Among Gay, Bisexual, and Other Men Who Have Sex With Men-United States, 2012-2014. J Infect Dis (2016) 0.77
Cervical Cancer Screening in Partly HPV Vaccinated Cohorts - A Cost-Effectiveness Analysis. PLoS One (2016) 0.77
Testing previous model predictions against new data on human papillomavirus vaccination program outcomes. BMC Res Notes (2014) 0.76
Anti-cancer vaccines - a one-hit wonder? Yale J Biol Med (2014) 0.76
Modeling the impact of the difference in cross-protection data between a human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and a human papillomavirus (HPV)-6/11/16/18 vaccine in Canada. BMC Public Health (2012) 0.76
The sexual ethics of HPV vaccination for boys. HEC Forum (2014) 0.76
Psychosocial determinants of parental human papillomavirus (HPV) vaccine decision-making for sons: Methodological challenges and initial results of a pan-Canadian longitudinal study. BMC Public Health (2016) 0.75
HPV Vaccination: Attitude and Knowledge among German Gynecologists. Geburtshilfe Frauenheilkd (2016) 0.75
Dissecting the indirect effects caused by vaccines into the basic elements. Hum Vaccin Immunother (2015) 0.75
Health Disparities in the Immunoprevention of Human Papillomavirus Infection and Associated Malignancies. Front Public Health (2015) 0.75
Health policy: HPV vaccination in boys - will the UK join the fight? Nat Rev Clin Oncol (2016) 0.75
Population benefits of HPV vaccination for boys: a complex equation. Evid Based Med (2012) 0.75
Women have a preference for their male partner to be HPV vaccinated. PLoS One (2014) 0.75
Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med (2007) 9.53
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet (2004) 8.09
Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet (2006) 7.83
HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention. Int J Epidemiol (2010) 7.72
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin (2012) 5.58
Population-level impact of the bivalent, quadrivalent, and nonavalent human papillomavirus vaccines: a model-based analysis. J Natl Cancer Inst (2012) 3.87
Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int J Cancer (2009) 3.64
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol (2012) 3.51
The epidemiology of genital human papillomavirus infection. Vaccine (2006) 3.28
Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis. Lancet Infect Dis (2012) 3.25
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. J Low Genit Tract Dis (2012) 3.15
Chapter 6: Epidemiology and transmission dynamics of genital HPV infection. Vaccine (2006) 2.95
Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis. Gynecol Oncol (2007) 2.90
Evaluation design for large-scale HIV prevention programmes: the case of Avahan, the India AIDS initiative. AIDS (2008) 2.78
A systematic review and meta-analysis of quantitative interviewing tools to investigate self-reported HIV and STI associated behaviours in low- and middle-income countries. Int J Epidemiol (2010) 2.59
Work situation after breast cancer: results from a population-based study. J Natl Cancer Inst (2004) 2.57
The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada. Vaccine (2007) 2.55
The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol Biomarkers Prev (2003) 2.52
Multiparameter calibration of a natural history model of cervical cancer. Am J Epidemiol (2007) 2.49
Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol Biomarkers Prev (2006) 2.39
Process of care failures in invasive cervical cancer: systematic review and meta-analysis. Prev Med (2007) 2.35
The forgotten half of the equation: randomized controlled trial of a male invitation to attend couple voluntary counselling and testing. AIDS (2011) 1.99
Delays in diagnosis and treatment among children and adolescents with cancer in Canada. Pediatr Blood Cancer (2008) 1.98
HAART and progression to high-grade anal intraepithelial neoplasia in men who have sex with men and are infected with HIV. Clin Infect Dis (2011) 1.95
Proportion of new HIV infections attributable to herpes simplex 2 increases over time: simulations of the changing role of sexually transmitted infections in sub-Saharan African HIV epidemics. Sex Transm Infect (2007) 1.89
Prevalence, clearance, and incidence of anal human papillomavirus infection in HIV-infected men: the HIPVIRG cohort study. J Infect Dis (2009) 1.89
Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies. Prev Med (2011) 1.89
Breast cancer survivors accurately reported key treatment and prognostic characteristics. J Clin Epidemiol (2005) 1.88
Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia. J Natl Cancer Inst (2003) 1.84
Wage losses in the year after breast cancer: extent and determinants among Canadian women. J Natl Cancer Inst (2008) 1.80
Viral load as a predictor of the risk of cervical intraepithelial neoplasia. Int J Cancer (2003) 1.78
The laboratory impact of changing syphilis screening from the rapid-plasma reagin to a treponemal enzyme immunoassay: a case-study from the Greater Toronto Area. Sex Transm Dis (2011) 1.77
Estimating the number needed to vaccinate to prevent diseases and death related to human papillomavirus infection. CMAJ (2007) 1.72
Type-specific duration of human papillomavirus infection: implications for human papillomavirus screening and vaccination. J Infect Dis (2008) 1.72
Cost-effectiveness of HPV 16, 18 vaccination in Brazil. Vaccine (2007) 1.71
Risk of HIV-1 transmission for parenteral exposure and blood transfusion: a systematic review and meta-analysis. AIDS (2006) 1.70
Management of low-grade cervical lesions in young women. CMAJ (2005) 1.69
Use of nonsteroidal anti-inflammatory drugs and prostate cancer risk: a meta-analysis. Int J Cancer (2010) 1.65
Assessing the gain in diagnostic performance when combining two diagnostic tests. Stat Med (2002) 1.65
Inequalities in Human Papillomavirus (HPV)-associated cancers: implications for the success of HPV vaccination. J Natl Cancer Inst (2013) 1.60
Understanding the differences between contrasting HIV epidemics in east and west Africa: results from a simulation model of the Four Cities Study. Sex Transm Infect (2007) 1.60
Heterosexual HIV-1 infectiousness and antiretroviral use: systematic review of prospective studies of discordant couples. Epidemiology (2013) 1.54
Reproductive health of adolescent girls perinatally infected with HIV. Am J Public Health (2007) 1.53
Modeling the sexual transmissibility of human papillomavirus infection using stochastic computer simulation and empirical data from a cohort study of young women in Montreal, Canada. Am J Epidemiol (2006) 1.53
Efficacy dilution in randomized placebo-controlled vaginal microbicide trials. Emerg Themes Epidemiol (2009) 1.52
Human papillomavirus infection and reinfection in adult women: the role of sexual activity and natural immunity. Cancer Res (2010) 1.50
Conceptualization and sources of costs from breast cancer: findings from patient and caregiver focus groups. Psychooncology (2005) 1.49
To what extent is the HIV epidemic in southern India driven by commercial sex? A modelling analysis. AIDS (2010) 1.48
Diagnosis delays in childhood cancer: a review. Cancer (2007) 1.44
Modeling human papillomavirus vaccine effectiveness: quantifying the impact of parameter uncertainty. Am J Epidemiol (2007) 1.38
Interim modelling analysis to validate reported increases in condom use and assess HIV infections averted among female sex workers and clients in southern India following a targeted HIV prevention programme. Sex Transm Infect (2010) 1.38
Condom use within non-commercial partnerships of female sex workers in southern India. BMC Public Health (2011) 1.37
Economic evaluation of human papillomavirus vaccination in developed countries. Public Health Genomics (2009) 1.35
Human papillomavirus infection and oral cancer: a case-control study in Montreal, Canada. Oral Oncol (2007) 1.34
Modifiable risk factors associated with clearance of type-specific cervical human papillomavirus infections in a cohort of university students. Cancer Epidemiol Biomarkers Prev (2005) 1.32
Dietary change after breast cancer: extent, predictors, and relation with psychological distress. J Clin Oncol (2002) 1.31
Predictors of cervical coinfection with multiple human papillomavirus types. Cancer Epidemiol Biomarkers Prev (2003) 1.31
Making prospective registration of observational research a reality. Sci Transl Med (2014) 1.31
Systematic review of orogenital HIV-1 transmission probabilities. Int J Epidemiol (2008) 1.28
p53 codon 72 polymorphism and cervical neoplasia: a meta-analysis review. Cancer Epidemiol Biomarkers Prev (2004) 1.26
Intensity of drug injection as a determinant of sustained injection cessation among chronic drug users: the interface with social factors and service utilization. Addiction (2004) 1.26
A dose-response relationship between exposure to a large-scale HIV preventive intervention and consistent condom use with different sexual partners of female sex workers in southern India. BMC Public Health (2011) 1.25
Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis. Int J Cancer (2012) 1.23
Visual inspection as a cervical cancer screening method in a primary health care setting in Africa. Int J Cancer (2006) 1.22
Human papillomavirus infections among couples in new sexual relationships. Epidemiology (2010) 1.20
The impact of out-migrants and out-migration on the HIV/AIDS epidemic: a case study from south-west India. AIDS (2008) 1.20
Understanding differences in predictions of HPV vaccine effectiveness: A comparative model-based analysis. Vaccine (2010) 1.18
Genital transmission of human papillomavirus in recently formed heterosexual couples. J Infect Dis (2011) 1.15
Prevalence and age distribution of human papillomavirus infection in a population of Inuit women in Nunavik, Quebec. Cancer Epidemiol Biomarkers Prev (2008) 1.14
Violence and HIV risk among female sex workers in Southern India. Sex Transm Dis (2013) 1.14
Health-related quality of life lost to rotavirus-associated gastroenteritis in children and their parents: a Canadian prospective study. Pediatr Infect Dis J (2010) 1.14
Burden of disease, health indicators and challenges for epidemiology in North America. Int J Epidemiol (2012) 1.12
The role of heterosexual anal intercourse for HIV transmission in developing countries: are we ready to draw conclusions? Sex Transm Infect (2009) 1.09
Report of the 2003 pan-Canadian forum on cervical cancer prevention and control. J Obstet Gynaecol Can (2004) 1.09
Epidemiologic approaches to evaluating the potential for human papillomavirus type replacement postvaccination. Am J Epidemiol (2013) 1.09
HIV treatment as prevention: optimising the impact of expanded HIV treatment programmes. PLoS Med (2012) 1.08
Human papillomavirus and cervical cancer: burden of illness and basis for prevention. Am J Manag Care (2006) 1.08
Use of non-steroidal anti-inflammatory drugs and prostate cancer risk: a population-based nested case-control study. PLoS One (2011) 1.07
A randomized controlled trial of Human Papillomavirus (HPV) testing for cervical cancer screening: trial design and preliminary results (HPV FOCAL Trial). BMC Cancer (2010) 1.07
Human papillomavirus type 33 polymorphisms and high-grade squamous intraepithelial lesions of the uterine cervix. J Infect Dis (2006) 1.07
Syphilis screening among female sex workers in Bangalore, India: comparison of point-of-care testing and traditional serological approaches. Sex Transm Infect (2009) 1.05
Human papillomavirus (HPV) DNA triage of women with atypical squamous cells of undetermined significance with cobas 4800 HPV and Hybrid Capture 2 tests for detection of high-grade lesions of the uterine cervix. J Clin Microbiol (2012) 1.05
Persistence of an incident human papillomavirus infection and timing of cervical lesions in previously unexposed young women. Cancer Epidemiol Biomarkers Prev (2009) 1.03
Out-of-pocket costs for accessing adjuvant radiotherapy among Canadian women with breast cancer. J Clin Oncol (2011) 1.03
Estimating vertically acquired HIV infections and the impact of the prevention of mother-to-child transmission program in Zimbabwe: insights from decision analysis models. J Acquir Immune Defic Syndr (2008) 1.02
Comprehensive control of human papillomavirus infections and related diseases. Vaccine (2013) 1.02
Dietary intake and risk of persistent human papillomavirus (HPV) infection: the Ludwig-McGill HPV Natural History Study. J Infect Dis (2003) 1.01
HLA polymorphisms and cervical human Papillomavirus infection in a cohort of Montreal University students. J Infect Dis (2007) 1.01
Human papillomavirus (HPV) types 16, 18, 31, 45 DNA loads and HPV-16 integration in persistent and transient infections in young women. BMC Infect Dis (2010) 1.00
Impact of high-risk sex and focused interventions in heterosexual HIV epidemics: a systematic review of mathematical models. PLoS One (2012) 1.00
Influence of postoperative infectious complications on long-term survival of lung cancer patients: a population-based cohort study. J Thorac Oncol (2013) 1.00
HIV transmission in serodiscordant heterosexual couples. BMJ (2010) 0.99
Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada. J Med Virol (2011) 0.99
Optimization of primary and secondary cervical cancer prevention strategies in an era of cervical cancer vaccination: a multi-regional health economic analysis. Vaccine (2008) 0.98